Native incretins prevent the development of atherosclerotic lesions in apolipoprotein E knockout mice

AIMS/HYPOTHESIS: Several lines of evidence suggest that incretin-based therapies suppress the development of cardiovascular disease in type 2 diabetes. We investigated the possibility that glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) can prevent the developm...

Descripción completa

Detalles Bibliográficos
Autores principales: Nagashima, M., Watanabe, T., Terasaki, M., Tomoyasu, M., Nohtomi, K., Kim-Kaneyama, J., Miyazaki, A., Hirano, T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2011
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3168747/
https://www.ncbi.nlm.nih.gov/pubmed/21786155
http://dx.doi.org/10.1007/s00125-011-2241-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3168747/
https://www.ncbi.nlm.nih.gov/pubmed/21786155
http://dx.doi.org/10.1007/s00125-011-2241-2

Ejemplares similares